Clinical TrialsSearch results
Number of results: 226
Other
- Randomized phase II study of best available 5-FU versus low-dose Paclitaxiel in gastric cancer with peritoneal metastasis refractory to 5-FU containing regimen(JCOG0407)
- gastric neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-09-08
Recruiting
- Adverse Event caused by AI-assisted endoscopy
- gastric neoplasm
- Kikuchi Hidezumi
- 2023-11-08
Other
- Randomized phase III study of 5-FU continuous infusion (5FUci) versus MTX+5-FU sequential therapy (MF) in gastric cancer with peritoneal metastasis (JCOG0106-MF, MF/5FU)
- gastric cancer with peritoneal metastasis
- Japan Clinical Oncology Group(JCOG)
- 2005-09-07
Other
- Randomized clinical trial about the period of antimicrobial prophylaxis administration in total gastrectomy for gastric cancer.
- Gastric cancer patients undergoing elective total gastrectomy
- Randomized clinical trial committee, Japan Society for Surgical Infection
- 2008-03-03
Other
- A Phase III Study of Docetaxel and S-1 versus S-1 in the Treatment of Advanced Gastric Cancer
- Gastric Cancer
- Japan Clinical Cancer Research Organization
- 2005-11-01
Other
- A randomized phase III trial of postoperative adjuvant oral fluoropyrimidine vs. sequential paclitaxel / oral fluoropyrimidine; and UFT vs. S1 for T3 / T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (SAMIT) Trial
- Gastric Cancer
- Young Leaders' Program (YLP), Nagoya University School of Medicine
- 2005-09-01
Other
- feasibility study on CPT-11/TS-1 sequential therapy for TS-1-resistant unresectable gastric cancer
- gastric cancer
- 1st Department of Internal Medicine,Hirosaki University, School of Medicine
- 2011-09-01
Recruiting
- A Randomised phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advaneced or recurrent gastric cancer resistant to S-1
- Gastric Cancer
- ECRIN
- 2009-10-01
Other
- Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-I: Prospective observational study
- first relapsed acute lymphoblastic leukemia in children
- Japanese Peditric Leukemia/Lymphoma Study Group
- 2009-06-01
Other
- Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-II: Multicenter phase II clinical trial for children with non-T-ALL in intermediate risk group stratified by the minimal residual disease (MRD).
- first relapsed acute lymphoblastic leukemia in children
- Japanese Peditric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-06-01